REAL WORLD EVIDENCE OF THE RISK OF A SECOND CANCER AMONG TESTICULAR CANCER PATIENTS AFTER CISPLATIN-BASED TREATMENT

被引：0
|
作者：
Luciano, S. [1 ]
Fazio-Eynullayeva, E. [2 ]
Kuranz, S. [1 ]
Stetson, B. [1 ]
机构：
[1] TriNetX Inc, Cambridge, MA USA
[2] TriNetX Inc, Revere, MA USA
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN183
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [31] Management of nausea in cancer patients treatment highly emetics cisplatin-based
    Couic-Marinier, Francoise
    ACTUALITES PHARMACEUTIQUES, 2012, 51 (515): : 46 - 48
  • [32] Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
    Haugnes, Hege S.
    Stenklev, Niels Christian
    Brydoy, Marianne
    Dahl, Olav
    Wilsgaard, Tom
    Laukli, Einar
    Fossa, Sophie D.
    ACTA ONCOLOGICA, 2018, 57 (08) : 1075 - 1083
  • [33] Acute ischaemic stroke following cisplatin-based chemotherapy for testicular cancer
    Kanjanapan, Yada
    Gilbourd, Daniel
    Pranavan, Ganesalingam
    BMJ CASE REPORTS, 2020, 13 (05)
  • [34] Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
    Shields, Lisa B. E.
    Daniels, Michael W.
    Mar, Nataliya
    Rezazadeh Kalebasty, Arash
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (03): : 183 - 194
  • [35] Disturbed diastolic cardiac function one year after cisplatin-based chemotherapy for testicular cancer
    Altena, R.
    Nuver, J.
    van den Berg, M. P.
    Smit, A. J.
    Sleijfer, D. T.
    Gietema, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [36] Changes in circulating endothelial cells (CECs) during treatment with cisplatin-based chemotherapy for testicular cancer
    Altena, R.
    De Haas, E. C.
    Tibbe, A. G.
    Smit, A. J.
    van Roon, A.
    Meijer, C.
    Boezen, M. H.
    van der Meer, J.
    Sleijfer, D. T.
    Gietema, J. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] Cisplatin-Based Therapy and CINV: Optimal antiemetics during germ cell testicular cancer treatment
    Mastrangelo, Meghan
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2018, 22 (02) : E31 - E36
  • [38] Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer
    Strumberg, D
    Brügge, S
    Korn, MW
    Koeppen, S
    Ranft, J
    Scheibert, G
    Reiners, C
    Möckel, C
    Seeber, S
    Scheulen, ME
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 229 - 236
  • [39] Complications during cisplatin-based primary chemotherapy in patients with testicular cancer: Is there a need for thromboembolic prophylaxis?
    Pfister, David J. K. P.
    Porres, Daniel
    Wolsky, Ingrid
    Thissen, Andrea K.
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [40] How to Manage Cisplatin-Based Chemotherapy-Related Cardiovascular Disease in Patients With Testicular Cancer
    Kadambi, Sindhuja
    Clasen, Suparna C.
    Fung, Chunkit
    JACC: CARDIOONCOLOGY, 2022, 4 (03): : 409 - 412
12345